Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
Canada: Long-term COVID-19 associated with psychiatric symptoms and cognitive impairment, research recently published in the journal Brain, Behavior,...
Read Full NewsPrograms offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.
Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.
A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.
1.
AI is useful in low-resource areas for triaging breast masses.
2.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
3.
More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.
4.
Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image
5.
Breast Cancer Incidence Rises in Asian American Women
1.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
2.
Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment
3.
Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance
4.
A Revolutionary Guide to Calculating Absolute Neutrophil Counts
5.
AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
4.
Understanding the causes of anemia in adults beyond nutritional deficiencies
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge